BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 10, 2010
View Archived Issues
Trophos claims new cytoprotective agents
Read More
Scynexis discloses new antiviral cyclosporin A derivatives
Read More
NeuroSearch discovers new anticonvulsant agents
Read More
Cannabidiol displays antiangiogenic activity in preclinical tests
Read More
RGS1, IL12A and MPHOSPH9/CDK2AP1 gene SNPs are linked to susceptibility to MS
Read More
CONDOR data disclosed on GI safety of celecoxib vs. diclofenac/omeprazole in arthritis
Read More
Aragon doses first patient in phase I/II ARN-509 trial in prostate cancer
Read More
Vectura and GSK sign license agreement for dry powder drug formulations
Read More
Pluristem presents preclinical in vivo data on PLX cell therapy for pain
Read More
FDA seeks injunction against Regenerative Sciences for cultured cell product
Read More
Celgene's pomalidomide receives E.U. orphan drug status for myelofibrosis
Read More
Nabilone shows promise to treat cannabis use disorders
Read More
Curis provides update on phase II vismodegib trial in advanced ovarian cancer
Read More
Obeticholic acid receives E.U. orphan drug status for primary biliary cirrhosis
Read More
SNS-032 shows moderate activity in phase I trial in B-cell malignancies
Read More
European researchers describe new Aurora kinase A inhibitors
Read More
EMA grants octenidine orphan drug status for sepsis in premature infants
Read More
Daiichi Sankyo presents new agents for treatment of osteoporosis
Read More
HBGF-1-coated biodegradable device receives E.U. orphan drug status for spinal cord injury
Read More
Repros receives positive feedback on Androxal from FDA
Read More
Teva Pharma reports on rasagiline in early Parkinson's disease
Read More
Tranilast obtains orphan drug status for prevention of scarring in glaucoma surgery
Read More
Endo submits NDA for crush-resistant oxymorphone to FDA and plans to acquire Penwest
Read More
Amarin advances phase III AMR-101 trials in patients with high trigliceride levels
Read More
GSK and Genmab report topline data on ofatumumab in chronic lymphocytic leukemia
Read More